Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2021 Jul 7;127(19):3700. doi: 10.1002/cncr.33549

Erratum to “MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy”

PMCID: PMC8565669  PMID: 34233011

This erratum corrects the following:

Elad S, Cheng KKF, Lalla RV, et al. Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126:4423‐4431. doi: 10.1002/cncr.33100

In the aforementioned article, in the section Natural and Miscellaneous Agents, the sentence should read as follows (correction bolded):

“This guideline is based on 2 RCTs showing that a glutamine dose from 10 to 30 g daily during RT‐CT may prevent OM.”

There was a typographical error: the unit should be grams, not milligrams.

The authors regret this error.

DOI:10.1002/cncr.33549

. Erratum to “MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy”. Cancer. 2021. 10.1002/cncr.33549


Articles from Cancer are provided here courtesy of Wiley

RESOURCES